Clinical Trials of VitalPLANT and Helichrysum Infusions in Adults ( VitalPlant_SMILJ )
NCT ID: NCT06866314
Last Updated: 2026-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2025-03-15
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trials of Two Helichrysum Infusions in Adults
NCT04866628
Helichrysum Italicum Infusion Ingestion in Humans
NCT04818905
Effect of Boswellia Serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers
NCT07109843
A Study on the Effects of VR-3 Herbal Blend Intake on Acute and Chronic Stress in Healthy Adults
NCT00741962
Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia
NCT01327014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Similarly, Helichrysum italicum (HI) is also widely used in traditional medicine. Lately, it has been shown that HI infusion consumption had a beneficial effect on anthropometric traits. Indeed, significant reductions in body weight, body mass index, and visceral and total body fat were observed in adults. Moreover, after four weeks of intervention, LDL decreased and serum antioxidant properties were improved. Therefore, consuming infusion could thus be recommended as a simple, profitable habit for individuals with traits of metabolic syndrome.
Therefore, the aim of our study is to evaluate the effects of VitalPLANT alone and VitalPlant+Helichrysum italicum on different components of the metabolic syndrome in adults presenting at least two components of metabolic syndrome and yet not receiving any medication. The components of metabolic syndrome (lipid profile, blood pressure, antrophometry, inflammation status, glucose levels) will be measured at baseline and one week after daily consumptions of either VitalPLANT alone or VitalPLANT+SMILJ. In between there will be one week of washout period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VitalPLANT
0.75 g of milled plant material (VitalPLANT)
Tea infusion VitalPLANT - Active comparator
Consumation of 200 mL of tea infusion (VitalPLANT) in the morning 30 min before breakfast for one week
VitalPLANT+Helichrysum Italicum
0.75 g of milled plant material (VitalPLANT) + 0.75 g of milled Helichrysum Italicum
Tea infusion VitalPLANT + Helichrysum Italicum - Experimental product
Consumation of 200 mL of tea infusion VitalPLANT + Helichrysum Italicum in the morning 30 min before breakfast for one week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tea infusion VitalPLANT - Active comparator
Consumation of 200 mL of tea infusion (VitalPLANT) in the morning 30 min before breakfast for one week
Tea infusion VitalPLANT + Helichrysum Italicum - Experimental product
Consumation of 200 mL of tea infusion VitalPLANT + Helichrysum Italicum in the morning 30 min before breakfast for one week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI more than 25
* clinical diagnosis of at least two components of metabolic syndrome
Exclusion Criteria
* medications for any component of metabolic syndrome
40 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of food technology Novi Sad
UNKNOWN
Josip Pančič Institute Belgrade
UNKNOWN
University of Primorska
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zala Jenko Praznikar
Associate Professor, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zala Jenko Pražniakr, phD
Role: PRINCIPAL_INVESTIGATOR
University of Primorska, Faculty of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Of Primorska Faculty of Health Sciences
Izola, Izola, Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VitalPLANT and SMILJ_clinical
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.